Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Defronzo

Showing results (51-60 of 313) with videos related to

Pageof 32
Sort By:
Expert Opinion on Drug Delivery|December 23, 2006
First approved inhaled insulin therapy for diabetes mellitusRucha Jani, Curtis Triplitt, Charles Reasner, et al.
Current Diabetes Reports|April 25, 2012
Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitusMuhammad A Abdul-Ghani, Luke Norton, Ralph A DeFronzo
Hospital Practice (1995)|May 18, 2013
Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitusRalph A Defronzo, Rucha J Mehta, Joel J Schnure
Postgraduate Medicine|December 31, 2014
Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetesStanley S Schwartz, Ralph A DeFronzo, Guillermo E Umpierrez
Metabolism: Clinical and Experimental|January 23, 2022
Insulin: The master regulator of glucose metabolismLuke Norton, Chris Shannon, Amalia Gastaldelli, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 18, 2003
Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patientsY Miyazaki, R Pipek, L J Mandarino, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 10, 2011
Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunctionJohn Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Diabetes Care|July 22, 2016
Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment AlgorithmJohn P H Wilding, Surya Panicker Rajeev, Ralph A DeFronzo
Diabetes, Obesity & Metabolism|April 13, 2026
Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization (STOP DIABETES)John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Diabetes|July 29, 2003
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patientsYoshinori Miyazaki, Helen He, Lawrence J Mandarino, et al.
Pageof 32

Showing results (51-60 of 313) with videos related to

Sort By:
Pageof 32
Expert Opinion on Drug Delivery|December 23, 2006
First approved inhaled insulin therapy for diabetes mellitusRucha Jani, Curtis Triplitt, Charles Reasner, et al.
Current Diabetes Reports|April 25, 2012
Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitusMuhammad A Abdul-Ghani, Luke Norton, Ralph A DeFronzo
Hospital Practice (1995)|May 18, 2013
Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitusRalph A Defronzo, Rucha J Mehta, Joel J Schnure
Postgraduate Medicine|December 31, 2014
Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetesStanley S Schwartz, Ralph A DeFronzo, Guillermo E Umpierrez
Metabolism: Clinical and Experimental|January 23, 2022
Insulin: The master regulator of glucose metabolismLuke Norton, Chris Shannon, Amalia Gastaldelli, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 18, 2003
Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patientsY Miyazaki, R Pipek, L J Mandarino, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 10, 2011
Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunctionJohn Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Diabetes Care|July 22, 2016
Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment AlgorithmJohn P H Wilding, Surya Panicker Rajeev, Ralph A DeFronzo
Diabetes, Obesity & Metabolism|April 13, 2026
Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization (STOP DIABETES)John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, et al.
Diabetes|July 29, 2003
Rosiglitazone improves downstream insulin receptor signaling in type 2 diabetic patientsYoshinori Miyazaki, Helen He, Lawrence J Mandarino, et al.
Pageof 32